INSP 📈 Inspire Medical Systems - Overview

Inspire Medical Systems Inc, a medical technology company, is primarily focused on developing and commercializing innovative, minimally invasive solutions to address obstructive sleep apnea (OSA) - a condition that affects millions of people worldwide, causing breathing disruptions during sleep due to partial or complete blockage of the airway. The company's flagship product, the Inspire system, utilizes neurostimulation technology to provide a safe and effective treatment option for patients with moderate to severe OSA, offering an alternative to traditional treatments such as continuous positive airway pressure (CPAP) therapy.

The Inspire system is designed to work by delivering mild hypoglossal nerve stimulation, which helps maintain an open airway during sleep, thereby reducing sleep disruptions and improving overall sleep quality. This technology has been developed to be minimally invasive, aiming to reduce the discomfort and complications associated with more invasive surgical procedures. Furthermore, the company is also engaged in the development of a novel, closed-loop solution that continuously monitors a patient's breathing patterns and automatically adjusts the stimulation as needed, ensuring a more personalized and effective treatment experience.

As a company, Inspire Medical Systems Inc was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. With a strong commitment to innovation and patient care, the company operates both in the United States and internationally, serving a diverse range of patients and healthcare providers. Its common stock is listed on the New York Stock Exchange (NYSE) under the ticker symbol INSP, and it falls under the Health Care Technology sub-industry within the GICS classification system. More information about the company and its products can be found on its website at https://www.inspiresleep.com, with the company's ISIN being US4577301090.